A186 ASSOCIATION OF ULCERATIVE COLITIS BOWEL URGENCY IMPROVEMENT WITH CLINICAL RESPONSE AND REMISSION

por Clemow, D B, Sapin, C, Hibi, T, Dubinsky, M C, Vermeire, S, Schreiber, S, Gibble, T H, Peyrin-Biroulet, L, Watanabe, M, Panaccione, R, Jones, J
Publicado 2023

Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventiona...

por Colombel, J.‐F., Jharap, B., Sandborn, W. J., Feagan, B., Peyrin‐Biroulet, L., Eichner, S. F., Robinson, A. M., Mostafa, N. M., Zhou, Q., Thakkar, R. B.
Publicado 2016

The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method

por Reinisch, W, Chowers, Y, Danese, S, Dignass, A, Gomollón, F, Haagen Nielsen, O, Lakatos, P L, Lees, C W, Lindgren, S, Lukas, M, Mantzaris, G J, Michetti, P, Moum, B, Peyrin-Biroulet, L, Toruner, M, Woude, J, Weiss, G, Stoevelaar, H
Publicado 2013

A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH CROHN’S DISEASE: 52 WEEK RESULTS FROM THE PHASE 3 FORTIFY STUDY

por Panaccione, R, Ferrante, M, Feagan, B G, Sandborn, W, Panes, J, Peyrin-Biroulet, L, Colombel, J, Schreiber, S, Dubinsky, M, Baert, F, Hisamatsu, T, Neimark, E, Huang, B, Liao, X, Song, A, Berg, S, Duan, W, Pang, Y, Pivorunas, V, Kligys, K, Wallace, K, D’Haens, G
Publicado 2022